CytoMed Therapeutics Ltd SEC filings GDTC
CytoMed Therapeutics Ltd has 132 filings in SEC EDGAR's recent list, going back to Sep 28, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 13, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 18, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 13, 2025 | — |
| S-8 | Employee stock plan registration | Jan 6, 2025 | — |
| 424B4 | Prospectus | Apr 17, 2023 | — |
| FWP | Free writing prospectus | Mar 31, 2023 | — |
| F-1/A | Filing | Mar 30, 2023 | — |
| F-1/A | Filing | Mar 28, 2023 | — |
| F-1/A | Filing | Mar 16, 2023 | — |
| FWP | Free writing prospectus | Feb 27, 2023 | — |
| F-1/A | Filing | Feb 21, 2023 | — |
| F-1/A | Filing | Feb 1, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Nov 18, 2022 | — |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GDTC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Singapore
- Headquarters
- 1 Commonwealth Lane, Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1873093
- Former names
- CytoMed Therapeutics Pte. Ltd. (until Nov 30, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.